Spotlight On Dyslipidemia

Dyslipidemia remains an important modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD), making effective lipid management a critical component of cardiovascular risk reduction. As evidence, treatment options, and clinical recommendations continue to evolve, our Spotlight On Dyslipidemia series is here to help you stay current on the latest advances and their implications for individualized care.